Segersvärd Heli, Sandholm Niina, Harjutsalo Valma, Tikkanen Heidi, Kosonen Riikka, Laine Mika, Tikkanen Ilkka, Groop Per-Henrik, Lakkisto Päivi
Minerva Foundation Institute for Medical Research, Biomedicum Helsinki 2, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Cardiovasc Diabetol. 2025 Aug 18;24(1):339. doi: 10.1186/s12933-025-02895-2.
Heme oxygenase 1 (HO-1), encoded by the HMOX1 gene is a highly inducible enzyme with multiple cardiovascular protective properties. Polymorphisms of the HMOX1 gene, especially a guanine-thymine dinucleotide repeat polymorphism (GTn), affects its transcriptional activity and is associated with cardiovascular complications in the general population. We studied the association of HMOX1 polymorphisms and HO-1 serum concentrations with vascular complications and all-cause mortality in individuals with type 1 diabetes (T1D).
The study population consists of individuals with T1D participating in the Finnish Diabetic Nephropathy Study (FinnDiane). We genotyped the HMOX1 GTn repeat (n = 3990), extracted from genome-wide genotyping data two single nucleotide polymorphisms (SNPs) (-413A/T upstream variant rs2071746, and + 99G/C p.Asp7Asn missense variant rs2071747; n = 4278), and measured the serum HO-1 concentrations (n = 861) from blood samples taken during their study visit. The GTn repeats were divided into short (S) and long (L) alleles where the cutoff point was L ≥ 30 repeats.
In men, the LL genotype was associated with ischemic cardiac events (LL 22.9% vs. SS/SL 17.0%, p = 0.001) and all-cause mortality (p = 0.031). The association was detected in all individuals (LL 19.5% vs. SS/SL 16%, p = 0.006) but not in women (LL 15.7% vs. SS/SL 14.9%, p = 0.657). For the -413A/T SNP, men with the AA genotype experienced ischemic cardiac events more frequently (21.0% vs. 17.4%, p = 0.044), but no differences were found for women or for men and women together. There were no differences between different genotypes of the + 99G/C variant regarding cardiovascular complications. Also, there was no difference in HO-1 serum concentrations between different genotypes (GTn repeat, -413A/T or + 99G/C). Men had higher HO-1 serum concentrations compared to women (3.12 ± 1.23 ng/ml vs. 2.64 ± 1.04 ng/ml, p < 0.001). In women, higher HO-1 serum concentrations were associated with cardiovascular disease and need for antihypertensive and lipid lowering medications.
The LL genotype of the HMOX1 GTn repeat and the AA genotype of -413A/T SNP were associated with ischemic cardiac complications and all-cause mortality in men, but not in women. Thus, the HMOX1 genotype may influence the development of cardiovascular complications in individuals with T1D in a sex-dependent manner.
由HMOX1基因编码的血红素加氧酶1(HO-1)是一种具有多种心血管保护特性的高度可诱导酶。HMOX1基因的多态性,尤其是鸟嘌呤-胸腺嘧啶二核苷酸重复多态性(GTn),会影响其转录活性,并与普通人群的心血管并发症相关。我们研究了1型糖尿病(T1D)患者中HMOX1多态性和HO-1血清浓度与血管并发症及全因死亡率的关联。
研究人群包括参与芬兰糖尿病肾病研究(FinnDiane)的T1D患者。我们对HMOX1 GTn重复序列进行基因分型(n = 3990),从全基因组基因分型数据中提取两个单核苷酸多态性(SNP)(-413A/T上游变异rs2071746和+99G/C p.Asp7Asn错义变异rs2071747;n = 4278),并测量他们在研究访视期间采集的血样中的血清HO-1浓度(n = 861)。GTn重复序列分为短(S)和长(L)等位基因,截断点为L≥30次重复。
在男性中,LL基因型与缺血性心脏事件(LL为22.9%,SS/SL为17.0%,p = 0.001)和全因死亡率(p = 0.031)相关。在所有个体中均检测到这种关联(LL为19.5%,SS/SL为16%),但在女性中未检测到(LL为15.7%,SS/SL为14.9%,p = 0.657)。对于-413A/T SNP,AA基因型的男性发生缺血性心脏事件的频率更高(21.0%对17.4%,p = 0.044),但在女性或男女合计中未发现差异。+99G/C变异的不同基因型在心血管并发症方面没有差异。此外,不同基因型(GTn重复序列、-413A/T或+99G/C)之间的HO-1血清浓度也没有差异。男性的HO-1血清浓度高于女性(3.12±1.23 ng/ml对2.64±1.04 ng/ml,p < 0.001)。在女性中,较高的HO-1血清浓度与心血管疾病以及使用抗高血压和降脂药物的需求相关。
HMOX1 GTn重复序列的LL基因型和-413A/T SNP的AA基因型与男性的缺血性心脏并发症和全因死亡率相关,但与女性无关。因此,HMOX1基因型可能以性别依赖的方式影响T1D患者心血管并发症的发生发展。